信陽毛尖(00362.HK)擬收購軟件及信息技術服務公司全部股權
格隆匯1月23日丨信陽毛尖(00362.HK)發佈公告,2020年1月23日,公司與兩名賣方訂立一份諒解備忘錄,據此,公司將收購目標公司全部股權。
目標公司在中國註冊成立,註冊資本為人民幣50萬元,由賣方全資擁有。目標公司主要從事軟件及信息技術服務,為中國企業提供雲服務、社交電子商務、人工智能、社羣服務及數字化轉換。
公告表示,諒解備忘錄預計能為集團帶來長期戰略價值。集團致力尋求新商機並計劃收購具有擴張集團業務巨大潛力的高質素業務以豐富集團的收入來源及提升股東的價值。可能收購事項(倘作實)將令集團能夠利用目標公司背景及專業知識進一步探索軟件及信息技術領域良好商機及新發展機會,且集團能夠得益於目標公司的競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.